Levels of anti-double-strained DNA but not antinuclear antibodies are associated with treatment efficacy and adverse outcomes in Crohn's disease patients treated with anti-TNFα. (Q50880210)
Jump to navigation
Jump to search
scientific article published in June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Levels of anti-double-strained DNA but not antinuclear antibodies are associated with treatment efficacy and adverse outcomes in Crohn's disease patients treated with anti-TNFα. |
scientific article published in June 2013 |
Statements
1 reference
Levels of anti-double-strained DNA but not antinuclear antibodies are associated with treatment efficacy and adverse outcomes in Crohn's disease patients treated with anti-TNFα. (English)
1 reference
Lajos S S Kiss
1 reference
Barbara D Lovasz
1 reference
Petra A Golovics
1 reference
Zsuzsanna Vegh
1 reference
Klaudia Farkas
1 reference
Tamas Molnar
1 reference
Karoly Palatka
1 reference
Maria Papp
1 reference
Anna Mohas
1 reference
Blanka K Szilagyi
1 reference
Szandra A Fekete
1 reference
Michael Mandel
1 reference
Peter L Lakatos
1 reference
1 June 2013
1 reference
22
1 reference
2
1 reference
135-140
1 reference
Identifiers
1 reference